Suchergebnisse - "Singh, Pankaj Kumar"

PubPharm (12)

1

Identifying novel putative ERK1/2 inhibitors via hybrid scaffold hopping -FBDD approach

enthalten in: Journal of biomolecular structure & dynamics | 2022

von Pathania, S. | Singh, P. | Narang, R. | +1

2

Pharmacophore-based designing of putative ROS-1 targeting agents for NSCLC

enthalten in: Molecular diversity | 2021

von Pathak, D. | Choudhary, S. | Singh, P. | +3

3

Structure based designing of triazolopyrimidone-based reversible inhibitors for kinases involved in NSCLC

enthalten in: Bioorganic & medicinal chemistry letters | 2019

von Singh, P. | Chaudhari, D. | Jain, S. | +1

4

YAP1-Mediated CDK6 Activation Confers Radiation Resistance in Esophageal Cancer - Rationale for the Combination of YAP1 and CDK4/6 Inhibitors in Esophageal Cancer

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2019

von Li, F. | Xu, Y. | Liu, B. | +20

5

Pharmacophore and molecular dynamics based activity profiling of natural products for kinases involved in lung cancer

enthalten in: Journal of molecular modeling | 2018

von Singh, P. | Silakari, O.

6

Putative dual inhibitors of Janus kinase 1 and 3 (JAK1/3) : Pharmacophore based hierarchical virtual screening

enthalten in: Computational biology and chemistry | 2018

von Jasuja, H. | Chadha, N. | Singh, P. | +3

7

Molecular dynamics guided development of indole based dual inhibitors of EGFR (T790M) and c-MET

enthalten in: Bioorganic chemistry | 2018

von Singh, P. | Silakari, O.

8

Design and development of PEGylated liposomal formulation of HER2 blocker Lapatinib for enhanced anticancer activity and diminished cardiotoxicity

enthalten in: Biochemical and biophysical research communications | 2018

von Shrivastava, R. | Trivedi, S. | Singh, P. | +4

9

Molecular dynamics and integrated pharmacophore-based identification of dual [Formula : see text] inhibitors

enthalten in: Molecular diversity | 2018

von Kaur, M. | Singh, P. | Singh, M. | +2

10

Chemotherapeutics-resistance "arms" race : An update on mechanisms involved in resistance limiting EGFR inhibitors in lung cancer

enthalten in: Life sciences | 2017

von Singh, P. | Silakari, O.